SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-20-018377
Filing Date
2020-09-25
Accepted
2020-09-25 17:20:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 152266
  Complete submission text file 0001493152-20-018377.txt   153937
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88372 | Film No.: 201201031
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108
Business Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A